Related references
Note: Only part of the references are listed.Lifestyle for Brain Health (LIBRA): a new model for dementia prevention
Olga J. G. Schiepers et al.
INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY (2018)
The future of dementia risk reduction research: barriers and solutions
S. Mitchell et al.
JOURNAL OF PUBLIC HEALTH (2017)
Midlife Work-Related Stress Increases Dementia Risk in Later Life: The CAIDE 30-Year Study
Shireen Sindi et al.
JOURNALS OF GERONTOLOGY SERIES B-PSYCHOLOGICAL SCIENCES AND SOCIAL SCIENCES (2017)
The Relationship Between Mobility Dysfunction Staging and Global Cognitive Performance
Magdalena I. Tolea et al.
ALZHEIMER DISEASE & ASSOCIATED DISORDERS (2016)
Cognitive leisure activities and future risk of cognitive impairment and dementia: systematic review and meta-analysis
Lauren A. Yates et al.
INTERNATIONAL PSYCHOGERIATRICS (2016)
The antibody aducanumab reduces Aβ plaques in Alzheimer's disease
Jeff Sevigny et al.
NATURE (2016)
Evaluating the Utility of a 'N-of-1' Precision Cancer Medicine Strategy: The Case for 'Time-to-Subsequent-Disease Progression'
Maurie Markman et al.
ONCOLOGY (2016)
Cognitive Reserve and the Prevention of Dementia: the Role of Physical and Cognitive Activities
Sheung-Tak Cheng
CURRENT PSYCHIATRY REPORTS (2016)
Nutrition and Dementia: Evidence for Preventive Approaches?
Marco Canevelli et al.
NUTRIENTS (2016)
Drug development in Alzheimer's disease: the path to 2025
Jeffrey Cummings et al.
ALZHEIMERS RESEARCH & THERAPY (2016)
Is it always Alzheimer's? Let's talk to our patients about cardiocerebrovascular prevention
Roberto Volpe et al.
AGING CLINICAL AND EXPERIMENTAL RESEARCH (2016)
Toward precision medicine in Alzheimer's disease
Christiane Reitz
ANNALS OF TRANSLATIONAL MEDICINE (2016)
P50: A candidate ERP biomarker of prodromal Alzheimer's disease
Deborah L. Green et al.
BRAIN RESEARCH (2015)
Analysing time to event data in dementia prevention trials: The example of the guidage study of EGB761A®
Bruno Scherrer et al.
JOURNAL OF NUTRITION HEALTH & AGING (2015)
A 2 year multidomain intervention of diet, exercise, cognitive training, and vascular risk monitoring versus control to prevent cognitive decline in at-risk elderly people (FINGER): a randomised controlled trial
Tiia Ngandu et al.
LANCET (2015)
Sarcopenia and impairment in cognitive and physical performance
Magdalena I. Tolea et al.
CLINICAL INTERVENTIONS IN AGING (2015)
Paths to Alzheimer's disease prevention: From modifiable risk factors to biomarker enrichment strategies
S. Lista et al.
JOURNAL OF NUTRITION HEALTH & AGING (2015)
Single-patient (n-of-1) trials: a pragmatic clinical decision methodology for patient-centered comparative effectiveness research
Naihua Duan et al.
JOURNAL OF CLINICAL EPIDEMIOLOGY (2013)
Toward defining the preclinical stages of Alzheimer's disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
Reisa A. Sperling et al.
ALZHEIMERS & DEMENTIA (2011)
The diagnosis of dementia due to Alzheimer's disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
Guy M. McKhann et al.
ALZHEIMERS & DEMENTIA (2011)
The diagnosis of mild cognitive impairment due to Alzheimer's disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
Marilyn S. Albert et al.
ALZHEIMERS & DEMENTIA (2011)
The n-of-1 clinical trial: the ultimate strategy for individualizing medicine?
Elizabeth O. Lillie et al.
PERSONALIZED MEDICINE (2011)
Dementia screening, biomarkers and protein misfolding Implications for public health and diagnosis
James E. Galvin
PRION (2011)
Share Paper
